VICEBIO LIMITED
Company number 11570257 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£11,962,599
Balance sheet as at 2023-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2018-09-14
- Employees
- 3 (2023 accounts)
- Registered office
- 410 Thames Valley Park Drive, Reading, Berkshire, United Kingdom, RG6 1PT
- Postcode
- RG6 1PT
- Capital
- 7 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-12-31
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-09-13
- Next due by
- 2026-09-27
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 8 resigned
Group structure
Controlled by Sanofi Foreign Participations B.V. (33302572) — since 2025-12-04
From persons-with-significant-control filings on the public register.
Contact details
- Website
- vicebio.com
Discover Sanofi's commitment to scientific innovation, our R&D focus areas, product pipeline, and digital approach to transforming the practice of medicine.
Previous company names
| Name | Date changed |
|---|---|
| MV1 MEDICINES LIMITED | 2019-04-13 |
Previous registered addresses 2
| Address | Changed on |
|---|---|
| 2ND FLOOR 168 SHOREDITCH HIGH STREET, LONDON, E1 6RA, UNITED KINGDOM | 2021-06-01 |
| 24 CHISWELL ST, LONDON, EC1Y 4YX, UNITED KINGDOM | 2021-06-01 |
Competitors Reading
This company ranks 32 among research and experimental development on biotechnology in Reading.
The class of 2018
36%
of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.